AzTrials
AzTrials

Metabolic SyndromeNCT01468220

Normobaric Hypoxic Training and Metabolic Syndrome

A study testing Endurance training in people with Metabolic Syndrome, run by Charite University, Berlin, Germany at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The patient numbers with metabolic syndrome and diabetes have doubled in the last decade. Data that physical exercise ameliorates the metabolic syndrome are convincing, although the mechanisms of the effect in man are not clear. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Metabolic Syndrome
What is being tested?
Endurance training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
27 participants
Where
1 siteGermany
Study dates
Jan 2012to Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Body mass index 27-40 kg/m2
  • Abdominal obesity (waist circumference >102 cm form men, >88 cm for women)
  • Two further diagnostic criteria of metabolic syndrome (ATP III Definition):
  • HDL cholesterin <40 mg/dl for men, <50 mg/dl for men
  • Triglyceride >150 mg/dl
  • Fasting glucose >110 mg/dl
Show all 9Show fewer
  • Blood pressure >135/80 mm Hg
  • Less than 2 hours of physical activity per week
  • Sinus rhythm

Who cannot join

  • Other relevant metabolic or cardiovascular diseases

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Charite University Medicine, ECRC

    Berlin, 13125

Other trials in Germany

About this study

Official title: Normobaric Hypoxic Training Compared to Ambient Training on the Course of the Metabolic Syndrome

The patient numbers with metabolic syndrome and diabetes have doubled in the last decade. Data that physical exercise ameliorates the metabolic syndrome are convincing, although the mechanisms of the effect in man are not clear. Numerous endocrine or molecular mechanisms modified by physical exercise are known to be hypoxia-sensitive, i.e. by hypoxia-inducible factor-1 (HIF-1) regulation. Thus, relative hypoxia may link physical exercise and modification of endogenous metabolism. Medical communities seem ill equipped to address the primary issues involved. The investigators have experience with normobaric "hypoxia chambers" and will now test a (physical exercise) training program, using state-of-the-art assessments available nowhere else in Germany. The investigators will compare hypoxia chamber, to ambient training, to test the notion that specific exercise conditions could regulate specific molecular pathways involved in the pathogenesis of the metabolic syndrome. Indeed, hypoxia chamber training could be superior to conventional training in terms of reducing cardiovascular risk factors or improving fitness. The investigators will test overall metabolism-related effects with a metabolic chamber. The investigators will test local metabolism with microdialysis during exercise routines, and the investigators will perform fat and muscle biopsies to investigate tissue-related effects. The investigators include experience from a broad-ranging spectrum. The investigators findings might improve understanding mechanisms linking physical exercise and endogenous metabolism. Furthermore, they could influence decision-making regarding non-pharmacological interventions.

Being tested
Endurance training
Keywords
tissue metabolism, skeletal muscle, adipose tissue, HIF
Medical subject headings
Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endurance trainingOther

    Endurance training three times per week over six weeks

Study groups in NCT01468220
Study groupRoleWhat they receive
normoxic trainingPlacebo comparator6 weeks of endurance training under normoxia
Receives: Other: Endurance training
hypoxic trainingActive comparator6 weeks of endurance training under hypoxia
Receives: Other: Endurance training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Increase in mitochondria number in skeletal muscle with exercise in hypoxia compared to normoxia

    Measured: Participants will be followed for the duration of the training program, an expected average of 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2011 (estimated)
  2. Study startJan 2012
  3. Primary completionJul 2017
  4. Study completionJun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01468220
Sponsor's protocol ID
Hypoxitrain 1
Other IDs
Hypoximet 1
Status last verified
Mar 2019
First submitted
15 Sep 2011
Last updated
4 Mar 2019
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Endurance training in people with Metabolic Syndrome, run by Charite University, Berlin, Germany at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Increase in mitochondria number in skeletal muscle with exercise in hypoxia compared to normoxia (time frame: Participants will be followed for the duration of the training program, an expected average of 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Normobaric Hypoxic Training and Metabolic Syndrome | AzTrials